Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

VANCOUVER, British Columbia -- Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic information services, under which Quest will validate and offer a lab-developed test based on the Augurex 14-3-3η (eta) biomarker in the United States. Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Picton Mahoney Asset Management Announces Monthly Distribution for Picton Mahoney Fortified Income Alternative Fund Exchange Traded Fund Units, Picton Mahoney Fortified Special Situations Alternative Fund Exchange Traded Fund Units, Picton Mahoney Fortifi
Loonie watch: Sub-70 cent Canadian dollar inching closer into view

New York judge rejects state efforts to shutter bitcoin mine over climate concerns
Cartier Closes Private Placement Financing